Myc, Oncogenic Protein Translation, and the Role of Polyamines

por Flynn, Andrea T., Hogarty, Michael D.
Publicado 2018

Mutations in PIK3CA are infrequent in neuroblastoma

por Dam, Vincent, Morgan, Brian T, Mazanek, Pavel, Hogarty, Michael D
Publicado 2006

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells

por McNerney, Kevin O., Karageorgos, Spyridon A., Hogarty, Michael D., Bassiri, Hamid
Publicado 2020

Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma

por Gamble, Laura D., Hogarty, Michael D., Liu, Xueyuan, Ziegler, David S., Marshall, Glenn, Norris, Murray D., Haber, Michelle
Publicado 2012

Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma

por Borankova, Karolina, Krchniakova, Maria, Leck, Lionel Y. W., Kubistova, Adela, Neradil, Jakub, Jansson, Patric J., Hogarty, Michael D., Skoda, Jan
Publicado 2023

BH3 Response Profiles From Neuroblastoma Mitochondria Predict Activity of Small Molecule Bcl-2 Family Antagonists

por Goldsmith, Kelly C., Lestini, Brian J., Gross, Michelle, Ip, Laura, Bhumbla, Ashish, Zhang, Xuemei, Zhao, Huaqing, Liu, Xueyuan, Hogarty, Michael D.
Publicado 2009

Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma

por Moghimi, Babak, Muthugounder, Sakunthala, Jambon, Samy, Tibbetts, Rachelle, Hung, Long, Bassiri, Hamid, Hogarty, Michael D., Barrett, David M., Shimada, Hiroyuki, Asgharzadeh, Shahab
Publicado 2021

A comprehensive characterization of rare mitochondrial DNA variants in neuroblastoma

por Calabrese, Francesco Maria, Clima, Rosanna, Pignataro, Piero, Lasorsa, Vito Alessandro, Hogarty, Michael D., Castellano, Aurora, Conte, Massimo, Tonini, Gian Paolo, Iolascon, Achille, Gasparre, Giuseppe, Capasso, Mario
Publicado 2016

Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma

por Yagyu, Shigeki, Iehara, Tomoko, Tanaka, Shiro, Gotoh, Takahiro, Misawa-Furihata, Akiko, Sugimoto, Tohru, London, Wendy B., Hogarty, Michael D., Teramukai, Satoshi, Nakagawara, Akira, Hiyama, Eiso, Maris, John M., Hosoi, Hajime
Publicado 2016

Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomis...

por de Alarcon, Pedro A., Matthay, Katherine K., London, Wendy B., Naranjo, Arlene, Tenney, Sheena C., Panzer, Jessica A., Hogarty, Michael D., Park, Julie R., Maris, John M., Cohn, Susan L.
Publicado 2017

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma

por Sausen, Mark, Leary, Rebecca J., Jones, Siân, Wu, Jian, Reynolds, C. Patrick, Liu, Xueyuan, Blackford, Amanda, Parmigiani, Giovanni, Diaz, Luis A., Papadopoulos, Nickolas, Vogelstein, Bert, Kinzler, Kenneth W., Velculescu, Victor E., Hogarty, Michael D.
Publicado 2012

Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression

por Lasorsa, Vito Alessandro, Formicola, Daniela, Pignataro, Piero, Cimmino, Flora, Calabrese, Francesco Maria, Mora, Jaume, Esposito, Maria Rosaria, Pantile, Marcella, Zanon, Carlo, De Mariano, Marilena, Longo, Luca, Hogarty, Michael D., de Torres, Carmen, Tonini, Gian Paolo, Iolascon, Achille, Capasso, Mario
Publicado 2016

MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cells

por Zanotti, Sofia, Vanhauwaert, Suzanne, Van Neste, Christophe, Olexiouk, Volodimir, Van Laere, Jolien, Verschuuren, Marlies, Van der Meulen, Joni, Mus, Liselot M., Durinck, Kaat, Tilleman, Laurentijn, Deforce, Dieter, Van Nieuwerburgh, Filip, Hogarty, Michael D., Decaesteker, Bieke, De Vos, Winnok H., Speleman, Frank
Publicado 2021

Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group

por DuBois, Steven G., Geier, Ethan, Batra, Vandana, Yee, Sook Wah, Neuhaus, John, Segal, Mark, Martinez, Daniel, Pawel, Bruce, Yanik, Greg, Naranjo, Arlene, London, Wendy B., Kreissman, Susan, Baker, David, Attiyeh, Edward, Hogarty, Michael D., Maris, John M., Giacomini, Kathleen, Matthay, Katherine K.
Publicado 2012

Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism

por Mandriota, Stefano J., Valentijn, Linda J., Lesne, Laurence, Betts, David R., Marino, Denis, Boudal-Khoshbeen, Mary, London, Wendy B., Rougemont, Anne-Laure, Attiyeh, Edward F., Maris, John M., Hogarty, Michael D., Koster, Jan, Molenaar, Jan J., Versteeg, Rogier, Ansari, Marc, Gumy-Pause, Fabienne
Publicado 2015

Epigenetic state determines inflammatory sensing in neuroblastoma

por Wolpaw, Adam J., Grossmann, Liron D., Dessau, Jessica L., Dong, May M., Aaron, Bailey J., Brafford, Patricia A., Volgina, Darya, Pascual-Pasto, Guillem, Rodriguez-Garcia, Alba, Uzun, Yasin, Arsenian-Henriksson, Marie, Powell, Daniel J., Bosse, Kristopher R., Kossenkov, Andrew, Tan, Kai, Hogarty, Michael D., Maris, John M., Dang, Chi V.
Publicado 2022

Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance

por Çoku, Jorida, Booth, David M, Skoda, Jan, Pedrotty, Madison C, Vogel, Jennifer, Liu, Kangning, Vu, Annette, Carpenter, Erica L, Ye, Jamie C, Chen, Michelle A, Dunbar, Peter, Scadden, Elizabeth, Yun, Taekyung D, Nakamaru‐Ogiso, Eiko, Area‐Gomez, Estela, Li, Yimei, Goldsmith, Kelly C, Reynolds, C Patrick, Hajnoczky, Gyorgy, Hogarty, Michael D
Publicado 2022

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy

por Erbe, Amy K., Wang, Wei, Reville, Patrick K., Carmichael, Lakeesha, Kim, KyungMann, Mendonca, Eneida A., Song, Yiqiang, Hank, Jacquelyn A., London, Wendy B., Naranjo, Arlene, Hong, Fangxin, Hogarty, Michael D., Maris, John M., Park, Julie R., Ozkaynak, M. F., Miller, Jeffrey S., Gilman, Andrew L., Kahl, Brad, Yu, Alice L., Sondel, Paul M.
Publicado 2017

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a repo...

por Niemas-Teshiba, Risa, Matsuno, Ryosuke, Wang, Larry L., Tang, Xao X., Chiu, Bill, Zeki, Jasmine, Coburn, Jeannine, Ornell, Kimberly, Naranjo, Arlene, Van Ryn, Collin, London, Wendy B., Hogarty, Michael D., Gastier-Foster, Julie M., Look, A. Thomas, Park, Julie R., Maris, John M., Cohn, Susan L., Seeger, Robert C., Asgharzadeh, Shahab, Ikegaki, Naohiko, Shimada, Hiroyuki
Publicado 2017

Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations

por Brady, Samuel W., Liu, Yanling, Ma, Xiaotu, Gout, Alexander M., Hagiwara, Kohei, Zhou, Xin, Wang, Jian, Macias, Michael, Chen, Xiaolong, Easton, John, Mulder, Heather L., Rusch, Michael, Wang, Lu, Nakitandwe, Joy, Lei, Shaohua, Davis, Eric M., Naranjo, Arlene, Cheng, Cheng, Maris, John M., Downing, James R., Cheung, Nai-Kong V., Hogarty, Michael D., Dyer, Michael A., Zhang, Jinghui
Publicado 2020